Log in
menu
RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact
All Categories
--------------
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
search
arrow_back_ios
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
arrow_forward_ios
Home
Answers
US Securities and Exchange Commission+Research and Development Expense+Agios Pharmaceuticals Inc+2019
attribution
history
edit
build
Question:
What is the company's aggregated costs regarding research and development?
Answer:
411M
USD
WikiRate ID:
11913979
Metric Designer:
US Securities and Exchange Commission
Metric Title:
Research and Development Expense
Company:
Agios Pharmaceuticals Inc
Year:
2019
Status:
Unverified - Added by Steward
Details
Years
12
calculations
0
Contributions
updated
about 2 years ago by
Vasiliki Gkatziaki
Review
Flag!
Source
history
edit
build
AGIOS PHARMACEUTICALS, INC.'s Annual Form 10-K report 2019
www.sec.gov
Answers
11
more_horiz
close_fullscreen
Original
file_download
Download
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
edit
Edit
build
Advanced
Comments